US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Crescita Therapeutics

News headline image
Crescita Reports First Quarter 2026 Results
From Crescita Therapeutics
Via Business Wire
Tickers PINK TSX:CTX
News headline image
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports Q4 and Fiscal 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports Third Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports Second Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita to Acquire Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Reports First Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports Q4 and Fiscal 2023 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports Second Quarter 2023 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Reports First Quarter 2022 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
News headline image
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Reports Second Quarter 2021 Results and Provides Corporate Update
From Crescita Therapeutics
Via Business Wire
Tickers TSX:CTX
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
News headline image
Crescita Reports First Quarter 2021 Results
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX